Oruka Therapeutics Files 8-K on Officer/Director Changes
Ticker: ORKA · Form: 8-K · Filed: Jul 1, 2025 · CIK: 907654
| Field | Detail |
|---|---|
| Company | Oruka Therapeutics, Inc. (ORKA) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, compensation
TL;DR
Oruka Therapeutics filed an 8-K on July 1, 2025, detailing changes to its board and executive compensation.
AI Summary
Oruka Therapeutics, Inc. filed an 8-K on July 1, 2025, reporting changes in its board of directors and certain officers, along with updates to compensatory arrangements. The filing also includes financial statements and exhibits. The company, formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC, is based in Menlo Park, CA.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is routine corporate disclosure and does not appear to contain significant negative financial or operational news.
Key Players & Entities
- Oruka Therapeutics, Inc. (company) — Registrant
- July 1, 2025 (date) — Date of Earliest Event Reported
- ARCA biopharma, Inc. (company) — Former Company Name
- NUVELO INC (company) — Former Company Name
- HYSEQ INC (company) — Former Company Name
- Menlo Park, CA (location) — Company Business Address
FAQ
What specific changes were made to the board of directors or certain officers?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers', but the specific details of these changes are not provided in the excerpt.
What is the significance of the 'Compensatory Arrangements of Certain Officers' item?
This item suggests that the filing includes information regarding the compensation plans or agreements for key executives within Oruka Therapeutics, Inc.
When was Oruka Therapeutics, Inc. incorporated?
Oruka Therapeutics, Inc. was incorporated in Delaware.
What were the previous names of Oruka Therapeutics, Inc.?
The company was formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC.
What is the primary business of Oruka Therapeutics, Inc. according to its SIC code?
According to its Standard Industrial Classification (SIC) code 2834, Oruka Therapeutics, Inc. is involved in Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Oruka Therapeutics, Inc. (ORKA).